ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure

BMC Cardiovascular Disorders

Volumn 14, Issue , 2014, Pages

  Bernardez Pereira, Sabrina ^a,b   Santos, Paulo C J L ^a   Krieger, Jose E ^a   Mansur, Alfredo J ^a   Pereira, Alexandre C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

ACTN3; Heart failure; Polymorphism; R577X

Indexed keywords

ACTN3 GENE; ADULT; ALLELE; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; AGED; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVOR; TIME;

ACTININ; ACTN3 PROTEIN, HUMAN;

ACTININ; ADULT; AGED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVORS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84904517758     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-90     Document Type: Article

References (19)

1. Shahzad K, Fatima A, Cadeiras M, Wisniewski N, Bondar G, Cheng R, Reed E, Deng M. Challenges and solutions in the development of genomic biomarker panels: a systematic phased approach. Curr Genomics 2012, 13(4):334-341.
2. Lunde PK, Sjaastad I, Schiotz Thorud HM, Sejersted OM. Skeletal muscle disorders in heart failure. Acta Physiol Scand 2001, 171(3):277-294.
3. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, North K. Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet 2001, 10(13):1335-1346.
4. Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leemputte M, Hespel P, Thomis MA. ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics 2007, 32(1):58-63.
5. Giolo SR, Krieger JE, Mansur AJ, Pereira AC. Survival analysis of patients with heart failure: implications of time-varying regression effects in modeling mortality. PLoS One 2012, 7(6):e37392.
6. Santos PC, Gagliardi AC, Miname MH, Chacra AP, Santos RD, Krieger JE, Pereira AC. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. Eur J Clin Pharmacol 2012, 68(3):273-279.
7. Santos PC, Santos PC, Soares RA, Santos DB, Nascimento RM, Coelho GL, Nicolau JC, Mill JG, Krieger JE, Pereira AC. CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population. BMC Med Genet 2011, 12:13.
8. Felker GM, Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000, 342(15):1077-1084.
9. Ochiai ME, Cardoso JN, Vieira KR, Lima MV, Brancalhao EC, Barretto AC. Predictors of low cardiac output in decompensated severe heart failure. Clinics (Sao Paulo) 2011, 66(2):239-244.
10. Yang N, Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003, 73(3):627-631.
11. Lucia A, Gomez-Gallego F, Santiago C, Bandres F, Earnest C, Rabadan M, Alonso JM, Hoyos J, Cordova A, Villa G, Foster C. ACTN3 genotype in professional endurance cyclists. Int J Sports Med 2006, 27(11):880-884.
12. Eynon N, Duarte JA, Oliveira J, Sagiv M, Yamin C, Meckel Y, Goldhammer E. ACTN3 R577X polymorphism and Israeli top-level athletes. Int J Sports Med 2009, 30(9):695-698.
13. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, Price TB, Angelopoulos TJ, Gordon PM, Moyna NM Pescatello LS, Visich PS, Zoeller RF, Seip RL, Hoffman EP. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol (1985) 2005, 99(1):154-163.
14. Seto JT, Lek M, Quinlan KG, Houweling PJ, Zheng XF, Garton F, MacArthur DG, Raftery JM, Garvey SM, Hauser N, Yang MA, Head SI, North KN. Deficiency of alpha-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Hum Mol Genet 2011, 20(15):2914-2927.
15. MacArthur DG, North KN. ACTN3: A genetic influence on muscle function and athletic performance. Exerc Sport Sci Rev 2007, 35(1):30-34.
16. Ma F, Yang Y, Li X, Zhou F, Gao C, Li M, Gao L. The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PLoS One 2013, 8(1):e54685.
17. von Haehling S, Steinbeck L, Doehner W, Springer J, Anker SD. Muscle wasting in heart failure: an overview. Int J Biochem Cell Biol 2013, 45(10):2257-2265.
18. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990, 81(2):518-527.
19. Whellan DJ, O'Connor CM, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston-Miller N, Fleg JL, Schulman KA, Piña IL, . HF-ACTION Trial Investigators Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J 2007, 153(2):201-211. HF-ACTION Trial Investigators.